Atlas Trials

X-Linked Retinitis Pigmentosa

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch X-Linked Retinitis Pigmentosa

RecordFirmDate
An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa (NCT04868916)Janssen Pharmaceutical K.K.2021-07-26
A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE) (NCT06333249)Beacon Therapeutics2021-04-13
Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene (NCT04671433)Janssen Research & Development, LLC2020-12-04
Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene (NCT04794101)Janssen Research & Development, LLC2020-12-04
4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP) (NCT04517149)4D Molecular Therapeutics2020-06-09
Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa (NCT03584165)NightstaRx Ltd, a Biogen Company2018-06-04
Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (NCT03316560)Beacon Therapeutics2018-04-16
Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP) (NCT03314207)Beacon Therapeutics2017-12-01
Natural History of the Progression of X-Linked Retinitis Pigmentosa (NCT04926129)NightstaRx Ltd, a Biogen Company2017-09-13
Long-term Follow-up Gene Therapy Study for RPGR- XLRP (NCT04312672)Janssen Research & Development, LLC2017-07-31
Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR) (NCT03252847)MeiraGTx UK II Ltd2017-07-31
A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112 (NCT03116113)Biogen2017-03-08

Track X-Linked Retinitis Pigmentosa automatically

Every clearance here is in the API, with alerts when new ones post.